The Coordinator General of the organization Prof Dr Iqbal Choudhary during an interaction with global technology leaders in ...
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback